DFT Calculations and In silico Study of Chlorogenic, Ellagic and Quisqualic acids as Potential Inhibitors of SARS-CoV-2 Main Protease Mpro

被引:6
|
作者
Shahab, Siyamak [1 ,2 ,3 ]
Kaviani, Sadegh [4 ]
Sheikhi, Masoome [5 ]
Almodarresiyeh, Hora Alhosseini [6 ]
Al Saud, Sultan [1 ,3 ]
机构
[1] Belarusian State Univ, ISEI BSU, Minsk, BELARUS
[2] Natl Acad Sci Belarus, Inst Phys Organ Chem, 13 Surganov Str, Minsk 220072, BELARUS
[3] Natl Acad Sci Belarus, Inst Chem New Mat, 36 Skarina Str, Minsk 220141, BELARUS
[4] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran
[5] Islamic Azad Univ, Gorgan Branch, Young Researchers & Elite Club, Gorgan, Golestan, Iran
[6] Meybod Univ, Sch Engn, Dept Mat Sci & Engn, Meybod 8961699557, Yazd, Iran
来源
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY | 2022年 / 12卷 / 01期
关键词
SARS-CoV-2 main protease M-pro; DFT; molecular docking; chlorogenic; Ellagic and Quisqualic acids; pharmacokinetic properties; COFFEE; METABOLITES; DERIVATIVES; DISCOVERY; TRANSPORT; UV/VIS; HUMANS;
D O I
10.33263/BRIAC121.061073
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
In the present work, at first, density functional theory calculations were performed to investigate the molecular structure of the Chlorogenic, Ellagic, and Quisqualic acids by CAM-B3LYP/MidiX level of theory. A detail of quantum molecular descriptors of the title compounds such as ionization potential (IP) and Electron Affinities (EA), Hardness (eta), Softness (S), Electronegativity (mu), Electrophilic Index (omega), Electron Donating Power (omega-), Electron Accepting Power (omega+) and Energy Gap (Eg) have been calculated. Pharmacokinetic properties of the title compounds and their bioactivity were investigated. In the following, a molecular docking study was carried out to screen for an effective available compound that may work as a strong inhibitor for the SARS-CoV-2 main protease Mpro. The binding energy between SARS-CoV-2 main protease Mpro and title organic acids showed a good binding affinity. Therefore, the Chlorogenic, Ellagic, and Quisqualic acids can be used for potential application against the SARS-CoV-2 main protease Mpro.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 50 条
  • [1] In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (Mpro)
    Victoria Adeola Falade
    Temitope Isaac Adelusi
    Ibrahim Olaide Adedotun
    Misbaudeen Abdul-Hammed
    Teslim Alabi Lawal
    Saheed Alabi Agboluaje
    In Silico Pharmacology, 9 (1)
  • [2] In silico approach identified benzoylguanidines as SARS-CoV-2 main protease (Mpro) potential inhibitors
    de Santiago-Silva, Kaio Maciel
    Camargo, Priscila
    da Silva Gomes, Gabriel Felix
    Sotero, Ana Paula
    Orsato, Alexandre
    Perez, Carla Cristina
    Nakazato, Gerson
    da Silva Lima, Camilo Henrique
    Bispo, Marcelle
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (16) : 7686 - 7699
  • [3] A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease
    Elkaeed, Eslam B.
    Eissa, Ibrahim H.
    Elkady, Hazem
    Abdelalim, Ahmed
    Alqaisi, Ahmad M.
    Alsfouk, Aisha A.
    Elwan, Alaa
    Metwaly, Ahmed M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [4] Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study
    Hossain, Rajib
    Mahmud, Shafi
    Khalipha, Abul Bashar Ripon
    Saikat, Abu Saim Mohammad
    Dey, Dipta
    Khan, Rasel Ahmed
    Rauf, Abdur
    Wadood, Abdul
    Rafique, Humaria
    Bawazeer, Sami
    Khalil, Anees Ahmed
    Almarhoon, Zainab M.
    Mabkhot, Yahia N.
    Alzahrani, Khalid J.
    Islam, Muhammad Torequl
    Alsharif, Khalaf F.
    Khan, Haroon
    MAIN GROUP CHEMISTRY, 2023, 22 (02) : 313 - 327
  • [5] In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease
    Abdelrady, Yousef A.
    Ashraf, Naeem Mahmood
    Hamid, Arslan
    Thabet, Hayam S.
    Sayed, Asmaa M.
    Salem, Shimaa H.
    Hassanein, Emad H. M.
    Sayed, Ahmed M.
    FUTURE VIROLOGY, 2023, 18 (05) : 295 - 308
  • [6] IN SILICO PREDICTION OF INHIBITORY POTENTIAL OF A PUNICALAGIN ß-ANOMER AGAINST SARS-COV-2 MAIN PROTEASE (MPRO)
    Monteiro, Norberto
    Monteiro, Vitoria
    Lima, Lorena
    Karolline, Anna
    Machado, Richele
    QUIMICA NOVA, 2022, 45 (10): : 1230 - 1235
  • [7] Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
    Yang, Yue
    Luo, Yi-Dan
    Zhang, Chen-Bo
    Xiang, Yang
    Bai, Xin-Yue
    Zhang, Die
    Fu, Zhao-Ying
    Hao, Ruo-Bing
    Liu, Xiao-Long
    ACS OMEGA, 2024, 9 (32): : 34196 - 34219
  • [8] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [9] In-silico drug repurposing for targeting SARS-CoV-2 main protease (Mpro)
    Sharma, Shilpa
    Deep, Shashank
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07) : 3003 - 3010
  • [10] In vitro and in silico studies of SARS-CoV-2 main protease Mpro inhibitors isolated from Helichrysum bracteatum
    Wahab, Gehad Abdel
    Aboelmaaty, Walaa S.
    Lahloub, Mohamed Farid
    Sallam, Amal
    RSC ADVANCES, 2022, 12 (29) : 18412 - 18424